mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.008 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.009 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.009 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |